In addition, we found that TDI01, a novel selective ROCK2 inhibitor, strongly inhibited ROCK2 activity in LPS-induced ALI/ARDS in vivo and TNFα-treated HUVECs in vitro, suggesting promising therapeutic prospects for ALI/ARDS. Here, TNF is linked to acute respiratory distress syndrome.